The Effect of Dipeptidyl Peptidase 4 Inhibition on Growth Hormone Secretion in Women With Polycystic Ovarian Syndrome
Status: Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 15 Sep 2019
Price : $35 *
At a glance
- Drugs Sitagliptin (Primary)
- Indications Cardiovascular disorders; Diabetes mellitus
- Focus Pharmacodynamics
- 15 Sep 2019 Results (n=18) published in the Journal of Clinical Endocrinology and Metabolism.
- 17 Jul 2019 Planned primary completion date changed from 1 Jul 2019 to 31 Dec 2019.
- 20 Jun 2019 Planned End Date changed from 1 Jul 2019 to 31 Dec 2019.